DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Tracleer (Bosentan) - Current Clinical Trials

 
 



Tracleer Related Clinical Trials

Effects of Bosentan (Tracleer) in the Course of Pulmonary Artery Hypertension Induced by Hypoxia [Completed]

Effect of Bosentan in Scleroderma Renal Crisis [Active, not recruiting]

Pulmonary Artery Remodelling With Bosentan [Completed]

Bosentan Therapy in Children With Functional Single Ventricle [Completed]

The Effect of Tracleer® on Male Fertility [Completed]

Safety and Efficacy Study of Bosentan for Intermittent Claudication in Peripheral Arterial Disease [Completed]

Treatment of Thromboangiitis Obliterans (Buerguer's Disease) With Bosentan [Completed]

Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study [Not yet recruiting]

Influence of OATP1B1 and CYP2C9 Genotypes on the Pharmacokinetics of Bosentan Before and During Clarithromycin [Completed]

Treatment of Resistant Port-wine Stains With Bosentan and Pulsed Dye Laser: a Pilot Study [Active, not recruiting]

Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443 [Completed]

Role of Endothelin-A (ETA) and Endothelin-B (ETB) Receptors in the Vasodilatory Response to Endothelin-3 (ET-3) [Completed]

Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension [Completed]

Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Bosentan After Oral Administration [Active, not recruiting]

Bosentan In Exercise Induced Pulmonary Arterial Hypertension in CongenitaL Heart diseasE [Recruiting]

Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary Hypertension [Completed]

Safety and Efficacy Study of Bosentan in Progressive Pulmonary Sarcoidosis [Terminated]

The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis [Not yet recruiting]

Bosentan Improves Clinical Outcome of Adults With Congenital Heart Disease or Mitral Valve Lesions Who Undergo CArdiac Surgery [Recruiting]

BREATHE 5-OL: Tracleer (Bosentan) in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology [Completed]

Persistent Pulmonary Hypertension of the Newborn [Terminated]

Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH) [Completed]

Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis [Completed]

Insulin Resistance in Pulmonary Arterial Hypertension [Terminated]

Bosentan in Children With Pulmonary Arterial Hypertension Extension Study [Completed]

Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II [Completed]

Pulmonary Arterial Hypertension in Children [Completed]

Preventive Effects of Bosentan on the Systemic Cardiovascular Consequence of Sleep Apnea [Completed]

Bosentan Use in Patients With Diabetic Nephropathy [Terminated]

FUTURE 3 Study Extension [Completed]

ENDOTHELION Study Group: Effect of Bosentan in NAION Patients [Not yet recruiting]

Effect of Bosentan in Patients With Metastatic Melanoma Treated With Dacarbazine (DTIC) [Completed]

Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis [Recruiting]

Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger Physiology [Completed]

Effect of Bosentan on Skin Fibrosis in Patients With Systemic Sclerosis [Completed]

Study of Placebo or Bosentan to Treat Patients With Single Ventricle Physiology. [Completed]

Influence of CYP3A4-induction by St. John's Wort on the Steady State Pharmacokinetics of Bosentan [Completed]

Transcranial Doppler in Multiple Sclerosis [Completed]

Bosentan and Pulmonary Endothelial Function [Completed]

Bosentan for Mild Pulmonary Vascular Disease in Asd Patients. [Completed]

Effects of Bosentan on Respiratory Mechanics [Terminated]

Pharmacogenomics in Pulmonary Arterial Hypertension [Recruiting]

Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) [Completed]

Bosentan in Children With Pulmonary Arterial Hypertension [Completed]

Placebo Controlled Trial of Bosentan in Scleroderma Patients [Terminated]

Bosentan in Digital Ulcers [Completed]

Combined Use of Angiography, Optical Coherence Tomography and Intravascular Ultrasound in Evaluation of Pulmonary Vascular Structure and Function in Patients With Pulmonary Arterial Hypertension Treated With Oral Bosentan [Withdrawn]

Bosentan for Severe Mitral Valve Dysfunction [Recruiting]

BUILD 3: Bosentan Use in Interstitial Lung Disease [Completed]

Endothelin Receptor Function and Acute Stress [Recruiting]

Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan [Recruiting]

Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension [Completed]

Endothelin Blockade in Patients With Single Ventricle Physiology [Completed]

A Study to Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue Disease [Not yet recruiting]

Early Therapy of Pulmonary Arterial Hypertension [Completed]

Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma [Completed]

Bosentan for Poorly Controlled Asthma [Terminated]

Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Patients [Completed]

Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary Hypertension [Completed]

Bosentan in Treatment of Pulmonary Arterial Hypertension [Completed]

Effect of Bosentan on Endothelial Function in Patients With Type 2 Diabetes [Completed]

Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands [Recruiting]

Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients Diagnosed With Pulmonary Hypertension (PH) [Terminated]

Examination of the Bronchoprotective Effect of Endothelin Receptor Blockade in Asthma [Not yet recruiting]

Bosentan in Systemic Sclerosis [Completed]

Effect of Bosentan on Exercise Capacity at High Altitude [Completed]

ET-blockade and Exercise-induced Vascular Adaptations in T2DM [Active, not recruiting]

A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET Study [Terminated]

Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Scleroderma Patients [Completed]

Combination Treatment With Bosentan and Sildenafil to Patients With Eisenmengers Syndrome [Completed]

Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH) [Terminated]

Open-label Study With Bosentan in Interstitial Lung Disease [Completed]

Treatment of Early Systemic Sclerosis by Bosentan [Terminated]

Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH) [Terminated]

Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension [Completed]

Comparison of Efficacy Different Treatment Regimens in Pulmonary Hypertension Secondary to Lung Disease and or Hypoxia [Recruiting]

Characterization and Detection of Prolonged Endothelin Receptors Antagonists Administration [Completed]

Treatment of Supine Hypertension in Autonomic Failure [Recruiting]

Drug Therapy and Surgery in Congenital Heart Disease With Pulmonary Hypertension [Recruiting]

Study Evaluating the Addition of Sildenafil to Bosentan Therapy in Pulmonary Arterial Hypertension [Withdrawn]

Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH) [Completed]

First-line Bosentan and Sildenafil Combination Therapy for Pulmonary Arterial Hypertension [Recruiting]

Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso� Compared to Other FDA Approved PAH Therapies [Completed]

The "VISION" Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertension [Terminated]

Effects of Non-Specific Endothelin-A Receptor Blockade on Ocular Blood Flow in Patients With Glaucoma [Completed]

Eisenmenger's Syndrome in Adults With CHD [Completed]

Pulmonary Hypertension in Trisomy 21 Patients [Completed]

To Compare the Pharmacokinetics of Traclear 62.5 mg Tablets and HGP1206 125mg 1 Tablet in Healthy Male Volunteers [Completed]

Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension [Active, not recruiting]

Effect of Pharmacologic Interaction Between ERAs and PDE-5 Inhibitors on Medication Serum Levels and Clinical Disease Status in Patients With PAH [Recruiting]

Prevention and Treatment of Digital Ulcers in Systemic Sclerosis [Recruiting]

Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH) [Recruiting]

COMPERA / COMPERA-KIDS [Recruiting]

Effects of Iloprost Treatment in Adult Patients With Pulmonary Arterial Hypertension Related to Congenital Heart Disease [Active, not recruiting]

Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH) [Active, not recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017